Back to trial details

Intake questionnaire

Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

Applying to Sarah Cannon Research Institute · Nashville, Tennessee

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Solid Tumor?
3. Are you able to travel to Nashville for study visits?